The estimated Net Worth of Cari Gallman is at least 121 千$ dollars as of 1 August 2024. Cari Gallman owns over 1,061 units of Bristol-Myers Squibb Co stock worth over 121,135$ and over the last few years Cari sold BMY stock worth over 0$.
Cari has made over 2 trades of the Bristol-Myers Squibb Co stock since 2024, according to the Form 4 filled with the SEC. Most recently Cari exercised 1,061 units of BMY stock worth 51,554$ on 1 August 2024.
The largest trade Cari's ever made was exercising 2,761 units of Bristol-Myers Squibb Co stock on 10 March 2024 worth over 134,157$. On average, Cari trades about 1,274 units every 48 days since 2023. As of 1 August 2024 Cari still owns at least 2,493 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Cari Gallman stock trades at the bottom of the page.
Cari's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over 318,151,721$ worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth 6,601,565$ . The most active insiders traders include Lamberto Andreotti、James M Cornelius、Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of 1,682,720$. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth 51,554$.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: